Detalhe da pesquisa
1.
SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer.
Cancer
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38358334
2.
Dietary fat in relation to all-cause mortality and cancer progression and death among people with metastatic colorectal cancer: Data from CALGB 80405 (Alliance)/SWOG 80405.
Int J Cancer
; 152(2): 123-136, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35904874
3.
Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance).
Cancer
; 129(23): 3724-3734, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37651160
4.
Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).
Ann Surg Oncol
; 30(3): 1354-1363, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36622529
5.
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: High-grade neuroendocrine neoplasm cohort.
Cancer
; 127(17): 3194-3201, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33882143
6.
Racial differences in survival and response to therapy in patients with metastatic colorectal cancer: A secondary analysis of CALGB/SWOG 80405 (Alliance A151931).
Cancer
; 127(20): 3801-3808, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34374082
7.
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
JAMA
; 325(13): 1277-1286, 2021 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33821899
8.
Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol.
Lancet Oncol
; 21(12): 1589-1601, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33125909
9.
What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine report.
Cancer
; 126(23): 5022-5029, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32970346
10.
In response: Diabetes is a risk factor for the progression and prognosis of COVID-19.
Diabetes Metab Res Rev
; 36(7): e3331, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32452598
11.
Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study.
Lancet Oncol
; 19(1): 101-114, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29169877
12.
ASO Visual Abstract: Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers - Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).
Ann Surg Oncol
; 30(3): 1364-1365, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36542251
13.
Phase II open label pilot trial of aprepitant and palonosetron for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately emetogenic FOLFOX chemotherapy for the treatment of colorectal cancer.
Support Care Cancer
; 26(4): 1273-1279, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29090385
15.
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
JAMA
; 317(23): 2392-2401, 2017 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28632865
16.
Next steps for adolescent and young adult oncology workshop: An update on progress and recommendations for the future.
Cancer
; 122(7): 988-99, 2016 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26849003
17.
Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005).
Cancer
; 121(13): 2193-7, 2015 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25827820
18.
S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors.
Oncologist
; 20(12): 1353-4, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26576593
19.
Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727).
Cancer
; 120(19): 2980-5, 2014 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25041791
20.
Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among patients with stage II or III rectal cancer (INT-0144; SWOG 9304).
Cancer
; 120(21): 3329-3337, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25041994